Drug
Deoxycholic Acid clinical trials
Also written Kybella, ATX-101, DWJ211 and Deoxycholate.
Includes 1 study of Hyodeoxycholic acid.
- studies test it
- 26
- open now
- 1
- in phase 3
- 8
- first study started
- 2007
Keep track of what changes. Save the Deoxycholic Acid studies recruiting or about to start, and get an email each week — studies that open, close, add sites or post results.
Watch these studiesHow studies write it
Studies that test it under each name
Studies by the year they started
26 studies that test it; most in 2019 (4)
| Year | Studies |
|---|---|
| 2007 | 3 |
| 2008 | 2 |
| 2009 | 1 |
| 2010 | 1 |
| 2011 | 2 |
| 2012 | 2 |
| 2013 | 2 |
| 2014 | 1 |
| 2017 | 1 |
| 2018 | 2 |
| 2019 | 4 |
| 2021 | 1 |
| 2022 | 1 |
| 2024 | 1 |
| 2025 | 2 |
By phase
A phase 1/2 study counts in both.
- Early Phase 1
- 1
- Phase 1
- 8
- Phase 2
- 5
- Phase 3
- 8
- Phase 4
- 4
- No phase
- 1
What it is tested for
Each study’s main condition, where its own words name it.
Who runs them
Industry 18 · Other 8
Kythera Biopharmaceuticals (12) · Massachusetts General Hospital (4) · Daewoong Pharmaceutical Co. LTD. (3) · The Maas Clinic (1) · AbbVie (1) · Zeltiq Aesthetics (1) · Juva Skin & Laser Center (1) · University of California, San Diego (1)
Often tested with
Tested in the same studies.
Polidocanol (2) · Lidocaine Hydrochloride/Epinephrine (1) · Loratadine (1) · Ibuprofen (1) · Phosphatidylcholines (1)
Studies
Open first, then newest update. How each study uses Deoxycholic Acid is read from its arms, and is right about nine times in ten.
Testing it · 26
- Assessing the Efficacy of Repeat, Monthly Treatments of Deoxycholate for NF1 Associated Cutaneous Neurofibromas (cNFs)Enrolling by invitationPhase 1Massachusetts General HospitalNCT06300502Written as Kybella
- Safety and Efficacy of Deoxycholate Treatment of Small Fatty Deformities ( SFD)CompletedPhase 4The Maas ClinicNCT07880301Written as Kybella
- A Study to Evaluate Patient Satisfaction With the Overall Face and Neck Appearance After Combined Treatment of OnabotulinumtoxinA, JUVÉDERM® Products, KYBELLA, CoolSculpting Elite and SkinMedica ProductsCompletedPhase 4AbbVieNCT06783621Written as KYBELLA
- Efficacy of Skin Cooling in Reducing Pain Associated With Non-invasive Treatments of Neurofibromatosis Type 1 Cutaneous NeurofibromasCompletedPhase 1Massachusetts General HospitalNCT06132165Written as Deoxycholic Acid
- Dosing and Tolerability of Deoxycholic Acid Vs. Polidocanol in the Treatment of Neurofibromatosis Type 1 Cutaneous NeurofibromasCompletedPhase 1Massachusetts General HospitalNCT06120036Written as Kybella
- Tolerability of Device Based Therapies for Neurofibromatosis Type 1 Cutaneous NeurofibromasCompletedPhase 1Massachusetts General HospitalNCT04730583Written as Kybella
- Evaluate the Efficacy and Safety of DWJ211 in Patient With Moderate or Severe Submental FatCompletedPhase 3Daewoong Pharmaceutical Co. LTD.NCT03946592Written as DWJ211
- Clinicial Trial to Evaluate the Efficacy and Safety of DWJ211 in Patient With Moderate or Severe Submental FatCompletedPhase 2Daewoong Pharmaceutical Co. LTD.NCT03224117Written as DWJ211
- Pharmacokinetics and Safety, Tolerability of DWJ211in Healthy VolunteersCompletedPhase 1Daewoong Pharmaceutical Co. LTD.NCT04159961Written as DWJ211
- Submental Study (Sequential Treatment Approach)CompletedPhase 4Zeltiq AestheticsNCT03510598Written as Kybella 20 MG in 2 ML Injection
- Efficacy and Safety of Deoxycholic Acid Injections for Removal of Adipose Tissue in the "Bra Strap Fat" RegionCompletedPhase 4Juva Skin & Laser CenterNCT04089722Written as Deoxycholic Acid
- Safety and Efficacy of Deoxycholic Acid Injection for Reduction of Upper Inner Thigh FatCompletedEarly Phase 1University of California, San DiegoNCT04054011Written as Deoxycholic Acid
- Safety Study of ATX-101 (Deoxycholic Acid) in Subjects With Mild or Extreme Fullness of Submental FatCompletedPhase 3Kythera BiopharmaceuticalsNCT02035267Written as Deoxycholic Acid
- Open-Label Study of Deoxycholic Acid for the Reduction of Localized Subcutaneous Fat in the Submental AreaCompletedPhase 3Kythera BiopharmaceuticalsNCT01426373Written as Deoxycholic acid injection
- Phase 2 Study for the Treatment of Superficial LipomasCompletedPhase 2Kythera BiopharmaceuticalsNCT00608842Written as Deoxycholic Acid Injection
- Deoxycholic Acid Injection for the Treatment of Superficial LipomasCompletedPhase 1Kythera BiopharmaceuticalsNCT00422188Written as Deoxycholic Acid Injection
- Patient Experience Study of Deoxycholic Acid InjectionCompletedPhase 3Kythera BiopharmaceuticalsNCT02007434Written as Deoxycholic Acid Injection
- Phase 2 Study of Deoxycholic Acid Injection (ATX-101) for the Reduction of Submental FatCompletedPhase 2Kythera BiopharmaceuticalsNCT00618618Written as Deoxycholic Acid Injection
- Phase 1-2 Study of Deoxycholic Acid Injection (ATX-101) for the Reduction of Submental FatCompletedPhase 1/2Kythera BiopharmaceuticalsNCT00618722Written as Deoxycholic Acid Injection
- Evaluation of Safety and Efficacy of Deoxycholic Acid Injection (ATX-101) in the Reduction of Submental FatCompletedPhase 3Kythera BiopharmaceuticalsNCT01305577Written as Deoxycholic acid injection
See all 26 studies that test Deoxycholic Acid →
Given in every arm · 1 — Deoxycholic Acid is usual care beside what is tested
As the comparator · 2 — what is tested is compared with Deoxycholic Acid
Codes
What other systems call Deoxycholic Acid · ClinicalTrials.gg INT007310
- MeSH (NLM) D003840Deoxycholic AcidConfirmed ClinicalTrials.gov, NLM, Wikidata
- UNII (FDA) 005990WHZZDEOXYCHOLIC ACIDConfirmed FDA, NLM, Wikidata
- RxNorm 3194Confirmed FDA, Wikidata
- Wikidata Q425680deoxycholic acidConfirmed FDA, NLM, Wikidata
- NCI Thesaurus C81042Deoxycholic AcidConfirmed FDA, Wikidata
- DrugBank DB03619One source Wikidata
| System | Code | Name there | Checked by |
|---|---|---|---|
| MeSH (NLM) | D003840 | Deoxycholic Acid | Confirmed ClinicalTrials.gov, NLM, Wikidata |
| UNII (FDA) | 005990WHZZ | DEOXYCHOLIC ACID | Confirmed FDA, NLM, Wikidata |
| RxNorm | 3194 | — | Confirmed FDA, Wikidata |
| Wikidata | Q425680 | deoxycholic acid | Confirmed FDA, NLM, Wikidata |
| NCI Thesaurus | C81042 | Deoxycholic Acid | Confirmed FDA, Wikidata |
| DrugBank | DB03619 | — | One source Wikidata |
Also registered as sodium desoxycholate (UNII 436LS6U35Y).
“Confirmed” means two independent publishers link the code to this drug; “one source”, one does and its name agrees.